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Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
21 
Toxic Anterior Segment Syndrome (TASS) 
and Prophylaxis Against Postoperative 
Endophthalmitis 
Rosario Díez, Lourdes Jordano and César Hita 
Hospital Universitario de Getafe 
Spain 
1. Introduction  
Cataract surgery with intraocular lens (IOL) implantation is the most frequently performed 
operation in people over 65 years old. It has high success rates and complications are rare, 
but they do occur and can be either infectious or non infectious. Since the 1980s cases have 
been reported, usually as series of cases, of important inflammation in the anterior segment 
of the eye sometimes even with hypopyon and tissue damage after cataract surgery due to 
the entrance into the eye of toxic substances. They were first referred to as sterile 
endophthalmitis even if only the anterior segment was involved. In 1992, Monson et al 
(Monson et al., 1992) termed it Toxic Anterior Segment Syndrome (TASS). 
2. Incidence 
TASS can present as sporadic cases or in outbreaks. Many eyes with TASS are never 
diagnosed and many are not reported because they are not severe or they represent a very 
low percentage of the total cataract surgeries performed, thus the real incidence rates for 
TASS are unknown. But when a few cases accumulate in a short period of time, specially if 
they are severe, surgical centres search for information so as to prevent future cases.  
3. Clinical spectrum 
TASS is an acute and sterile anterior segment inflammatory reaction which usually presents 
after anterior segment surgery. Its incidence is unknown and it is due to the entrance of 
toxic but non infectious substances into the eye. It typically starts within 12 to 48 hours of 
intraocular surgery, but it can also occur even later.  Symptoms include blurry vision and 
minimal to moderate ocular pain. Signs such as inflammatory cells or flare or even fibrin in 
aqueous humour, and diffuse (limbus to limbus) corneal oedema without vitreous 
involvement are characteristic (Figure 1). Most of the cases are reported after uneventful 
cataract surgery. Recently, TASS after phakic IOL surgery or vitrectomy has also been 
reported. Although many symptoms and signs are similar to those of endophthalmitis, 
TASS characteristically affects the anterior segment and is Gram stain and culture negative 
and improves with steroid treatment. 
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Fig. 1. Cornea oedema and fibrin on the IOL 
Inflammation can be very severe resulting in hypopyon and fibrin formation due to the 
leakage of the blood-aqueous barrier. Limbus-to-limbus corneal oedema is a very typical 
sign resulting from diffuse endothelial damage. In some cases, severe tissue damage can 
lead to corneal decompensation requiring Descemet´s Stripping Automated Endothelial 
Keratoplasty or Penetrating Keratoplasty. Epithelial downgrowth over Descemet´s 
membrane has also been reported as a complication of TASS by Wallace, which required 
surgical treatment (Wallace et al., 2007). In early stages of TASS patients can present with 
low intraocular pressure. Permanent damage to the trabecular meshwork may cause ocular 
hypertension or secondary glaucoma which may require filtering procedures or tube shunt 
devices. Iris damage may cause a fixed irregular and/or dilated pupil. 
4. Differential diagnosis 
The differential diagnosis of (infectious) endophthalmitis can be challenging but there are 
some clues which can be helpful to diagnose TASS. TASS starts in the early postoperative 
period, usually within the first 24 hours. Inflammation is limited to the anterior structures of 
the eye and responds to either topical or oral steroids which can be given as a trial under 
strict monitoring as a steroid can improve TASS but unfortunately can theoretically 
exacerbate endophthalmitis if given too early in the course of treatment of the latter. There is 
a diffuse limbus to limbus oedema in TASS, pain is minimal or absent, and usually there is 
no lid swelling, conjunctival chemosis or discharge.  
Unfortunately, none of the above mentioned symptoms and signs totally rule out the 
possibility of postoperative endophthalmitis. Gram stain and cultures from aqueous and 
vitreous taps are always negative in TASS but this could also happen in endophthalmitis 
when either the sample is too scarce or the bacterial count is too low. Pijla et al and the 
Endophthalmitis Vitrectomy Study reported that only 65 to 70% of all infectious 
endophthalmitis cultures were positive (Pijla et al., 2010) (Endophthalmitis Vitrectomy 
Study Group, 1995). Therefore, it should be remembered that the primary objective if  
suspecting TASS in a patient is to rule out postoperative infectious endophthalmitis, because 
postponing its diagnosis and treatment could be blinding for the eye´s functionality and 
cause severe permanent damage to the anatomy of the eye.  
5. Aetiology 
As mentioned above, the aetiology of TASS is not infectious. It has been associated with 
many entities that reach the interior of the eye at any time during the surgery in the 
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operating theatre. They can be divided into extraocular substances which penetrate in the 
anterior chamber during or after surgery (topical antiseptics, glove powder or topical 
ointment), substances associated with the surgical procedure (anaesthetics, preservatives, 
inadequately reconstituted balanced solutions, ocular viscoelastic devices, mitomicin C or 
intraocular lenses) and irritants on the surface of intraocular surgical devices due to 
insufficient cleaning/flushing (detergents, gram-negative endotoxins in ultrasonic bath 
water, metal degradation in the surgical instruments or impurities in autoclave vapour). 
Many of the later are associated with reusable instruments. 
TASS is usually reported as outbreaks which cause great concern in the surgical team. The 
broad spectrum of aetiologies mentioned above makes it very hard to know the real cause 
when TASS is present. Endothelial toxicity has been associated with many intraocular drugs 
and may be influenced by chemical composition, the concentration, the pH, or the 
osmolality of the medication or vehicle or the addition of preservatives. 
Breebart et al and Parikh et al studied the effect of intraocular irrigating solutions, 
instrument related contaminants and intraocular drugs on corneal endothelium (Breebaart 
et al., 1990) (Parikh & Edelhauser, 2003) (Parikh et al., 2002). They concluded that the initial 
rupture of endothelial cell junctions and the acute lost of its barrier function was the cause of 
the corneal oedema seen with TASS. Whether the cornea returns to its preoperative status in 
absence of oedema depends on the remaining endothelial cells and their capacity to cover 
the damaged area where cells where lost. 
The main factors involved in TASS are described in further detail as follows. 
5.1 Preservatives 
It is of capital importance that drugs injected in the anterior chamber are preservative-free. 
Benzalkonium chloride (BAK) was involved in several TASS cases (Liu et al., 2001) 
(Eleftheriadis et al., 2002). Topical benzalkonium chloride rarely affects the endothelium 
when used properly. Sodium metabisulphite has also been involved in TASS (Avisar & 
Weinberger, 2010). It is used mixed with epinephrine when the latter is used in irrigating 
solutions to maintain good intraoperative pupil dilation (Data from Spain).  
5.2 Intracamerular anaesthetics 
Preservative free 0.5% bupivacaine and preservative free 2% lidocaine were reported to 
increase corneal thickness and opacification (Kadonoso et al, 1998). Conversely, the use of 
preservative-free 1% lidocaine has proved to be safe during phacoemulsification cataract 
surgery as it rapidly gets diluted to less significant concentrations in the anterior chamber so 
is washed off the cornea and iris to non-toxic level during phacoemulsification (Heuermann 
et al., 2002).  
5.3 Balanced saline solution (BSS) and endotoxines 
Kutty et al found that the existence of endotoxines in balanced saline solution (BSS) was 
responsible for an outbreak of TASS (Kutty et al., 2008). Further more, medications added to 
BSS can be another potential source of TASS.  
5.4 Maintenance of surgical materials 
Proper cleaning of surgical material is of cardinal importance in TASS prophylaxis as 
inadequate cleaning of phacoemulsification and irrigation/aspiration (I/A) handpieces is 
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the most frequently identified practice associated with TASS. Residual ophthalmic 
viscoelastic devices (OVD), debris or chemical substances used in the cleaning protocol can 
deposit in the inner and outer surfaces of reusable instruments if they are not properly 
removed. This is more likely to happen with reusable surgical materials such as cannulas, 
phacoemulsification handpieces and I/A tips. Both Parikh and Jun concluded that both 
enzymatic and non-enzymatic detergents used in instrument cleaning can eventually be 
deposited in the lumen of these and damage endothelium of rabbit and human eyes (Parikh 
et al., 2002)  (Jun & Chung, 2010). Using detergents in wrong concentrations is another cause 
of TASS. Instruments processed with detergents should be rinsed with abundant sterile 
distilled or sterile deionized water. Needless to say, disposable material should never be 
reused. When instruments are sterilized they can also get contaminated. Ultrasonic baths 
dislodge dried debris from instruments, especially OVDs. Gram-negative bacteria can be 
found in water baths, ultrasound baths and autoclave reservoirs. This bacteria are destroyed 
during heat sterilization but their heat-stable bacterial wall endotoxines remain intact and 
can deposit on instruments (Kreisler et al., 1992) (Holland & Morck, 2007) (Andonegui et al., 
2009). Another author (Hellinger et al., 2006) found sulphate, copper, zinc or silica 
impurities in the autoclave steam moisture.  
5.5 Denatured ophthalmic viscoelastic devices 
OVD can remain adherenet to the lumen of cannulas and reusable I/A tips when these are 
not correctly flushed after surgery. During sterilization OVD are denatured becoming 
hazardous in the anterior segment (Mathys et al., 2008).  
5.6 Antibiotics 
Administration of intraocular antibiotics during surgery is a very common practice. Gills 
recommended vancomycin and gentamicin in the irrigating solution during cataract surgery 
for postoperative endophthalmitis prophylaxis (Gills, 1991). There is increasing concern 
about the development of vancomycin-resistant bacterial strains, especially because this 
antibiotic is used as a last-step drug for gram-positive bacteria. Even more, macular toxicity 
has been associated with gentamicin use in irrigating solutions and when injected 
intravitreally even though Ball did not find a macular thickness increase with the use of a 
combination of these two antibiotics in cataract surgery (Ball & Barret, 2006). Furthermore, 
the concentration of these antibiotics used in irrigating solutions and the duration that they 
are in contact with bacteria responsible for endophthalmitis are not enough to be effective, 
based on their bactericidal or bacteriostatic characteristics (Peck et al., 2010). Other authors 
described the use of intracameral cefotaxime (Kramann et al., 2001), cefazolin (Garat et al., 
2005) (Romero et al., 2006), and cefuroxime (Montan et al., 2002) (Díez et al., 2009), but no 
toxicity has been reported. Nevertheless, there is always a possibility that these antibiotics 
could result in TASS due to an error in drug concentration or pH. This highlights the role of 
specially trained pharmacy staff. 
5.7 Autoclave 
Autoclaves must be periodically checked for preventive maintenance as recommended by 
manufacturer´s direction. Even more, it is mandatory to check for this daily or, at least, 
weekly. Hellinger reported a case of TASS due to the quality of the water and vapour of a 
vapour generator autoclave (Hellinger et al., 2006). Sulphate, nickel, copper or zinc in 
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vapour condensations can cause TASS outbreaks, which are specially severe with copper 
and zinc particles. When maintenance of the autoclave is poor this can result in an 
important source of debris. Thus, water composition used in autoclaves should be 
checked and substituted, if necessary, by deionized and ultrafiltered water. 
Glutaraldehide should not be used for sterilization as it is extremely toxic when 
insufficiently rinsed instruments contact cells of the anterior segment of the eye. Plasma 
gas sterilization promotes metal degradation in cannuled instruments and secondarily can 
cause TASS (Duffy et al., 2000).  
5.8  
Even though TASS is defined as an acute inflammation, it is not rare to find TASS delayed 
days after surgery. It is usually caused by intraocular lenses (chemicals used in packaging, 
polishing, cleaning or sterilization of the lens) or even ocular ointments (Figure 2). An 
outbreak was reported by Werner when ocular ointment containing petroleum was 
associated to tight ocular postoperative patching (Werner et al., 2006).  
 
 
Fig. 2. Intraocular ointment drop in the anterior chamber 
5.9 Glove powder 
When powder enters the eye it can result in TASS. But some powder-free gloves release a 
compound that causes TASS even if gloves merely touch the IOL during surgery.  
5.10 Others drugs 
Five cases of severe intraocular inflammation that developed after an intravitreal injection 
of the same lot of bevacizumab have recently been reported. Taking all observations 
together, the authors suggest that the cause of the sterile endophthalmitis associated with 
lot B3003B01 of bevacizumab was the result of some toxic byproduct whose concentration 
may not be high enough when bevacizumab is given systemically. The degeneration 
during the storage may increase its toxicity, and the eyes sensitized by repeated 
intravitreal bevacizumab may respond to the increased antigenicity (Sato et al., 2010). 
Also, two cases of TASS have been reported resulting from impurities in generic trypan 
blue that was administered intracamerally to improve visualization of the capsule. The 
corneal oedema persisted and the patients developed endothelial and trabecular 
meshwork damage. Penetrating keratoplasty was performed in both cases (Buzard et al., 
2010).  
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6. Management of TASS 
The treatment of TASS is centred on dampening the inflammation because once the toxic 
agent penetrates the anterior segment of the eye it causes immediate damage and 
unfortunately washing out the toxins is not effective in reducing the intense inflammatory 
reaction. 
When an acute postoperative inflammatory reaction is present, the first thing to do is to rule 
out infectious endophthalmitis. Once this has been done hourly topical 1% prednisolone 
acetate should be started. Close follow-up is mandatory in order to detect worsening 
inflammation or stabilization of the patient´s condition. Of course, should the inflammation 
increase, even if cultures or gram stain results are negative, it is strongly recommended to 
initiate treatment for infectious endophthalmitis given the potentially catastrophic 
consequences of failing to treat the later condition quickly. Slit lamp evaluation is useful to 
document corneal oedema and fibrin or cells in the anterior chamber. 
Intraocular pressure can initially decrease secondary to trabeculitis and in later stages can 
increase secondary to permanent trabecular meshwork damage. The eye should undergo 
gonioscopic exploration if corneal oedema allows it so as to inspect for the development of 
peripheral anterior synechias. Confocal microscopy, where available, allows determination 
of endothelial cell lost and study if permanent corneal damage is present. The final result 
will depend on the type of toxic, its concentration and the time it remains in the anterior 
chamber, and how long treatment was delayed. Mild cases of inflammation will recover 
corneal transparency in a few days or weeks, whilst moderate cases can exhibit a certain 
level of corneal oedema and/or ocular hypertension. The most severe cases will associate 
prolonged corneal oedema, corneal opacity, ocular hypertension or glaucoma, chronic 
anterior uveitis, cystoid macular oedema secondary to chronic inflammation and a fixed 
midriatic pupil secondary to iris damage.  Ocular rehabilitation may include queratoplasty, 
trabeculectomy or tube shunt devices.  
7. What to do in TASS outbreaks? TASS prevention 
The most important thing to do is to create a team where all surgical staff are represented: 
surgeons, nurses, sterilization area staff, pharmacists, and ideally preventive medicine or 
public health doctors. The medical records from patients who developed TASS should be 
available for the team who should document the surgical procedure, clinical presentation, 
the first time the inflammatory process was diagnosed, therapeutic approach and follow up. 
Furthermore, data recording the names of everyone in the surgical team, anaesthetics, 
intraocular drugs or viscoelastic devices, intraocular lenses and surgical incidences should 
be registered and ready to be reviewed. It is important that lot or batch numbers of drugs, 
substances and intraocular lenses are documented. Practice protocols must be reviewed to 
detect any mistakes during their application. This is very important for those members of 
staff responsible for cleaning and sterilization (Mammalis et al., 2006). 
The authors believe that reusable instruments should be replaced regularly, specially 
cannulas and I/A tips, even though lumen surface irregularities or deposits are not evident. 
Of extreme importance is to rinse with sterile deionized water both the irrigation and 
aspiration ports and the I/A tips of the phacoemulsifier. Because gram-negative bacteria 
growth is frequent in ultrasound water baths this water should be replaced daily. 
To learn more about instrument cleaning, disinfection and sterilization measures we 
recommend the Recommended Practices for Cleaning and Sterilizing Intraocular 
Instruments (Hellinger et al, 2007). 
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On the other hand, both irrigating solutions and any kind of intraocular medication should 
be correctly reconstituted. The authors believe that the operating room nurse in charge of 
intraocular drugs should repeat in a firm, loud voice the name of the substances he or she 
handles to the surgeon. It is also important to make sure that every intraocular medication is 
preservative-free and is of the proper concentration. This is specially important for 
epinephrine (adrenaline), which is frequently added to irrigating solutions, and 
intracamerular anaesthetics or antibiotics. It is important to note that lidocaine, indocyanine 
green, trypan blue and acetylcholine chloride are mixed with BSS instead of sterile water. 
As most of the reported outbreaks of TASS are related to cleaning, disinfection and 
sterilization or reusable intraocular material, these should be the most thoroughly reviewed 
steps (Holland et al., 2007). Therefore, when an outbreak of TASS is detected the 
maintenance of autoclave should be emphasised as well as improving cleaning, disinfection 
and sterilization practices. Of great importance is following the directions for management 
of equipment provided by the manufacturers.  
It is mandatory to report TASS cases to Regional or National Public Health Departments 
depending on each country´s organization.  
8. Conclusions 
Toxic Anterior Segment Syndrome is a challenging postsurgical inflammatory process both  
as isolated case or as outbreak. Today its clinical evolution is well-known. It is of capital 
importance to rule out infectious endophthalmitis because prompt diagnosis and treatment 
ensures better functional results. The low incidence or mild intraocular inflammation due to 
TASS or the fact that it is a sterile inflammation should not make clinicians underestimate 
this complication.  
Unfortunately, it can be as destructive as infectious postoperative endophthalmitis. This fact 
highlights that either cleaning, disinfection or sterilization protocols should be improved or 
that some kind of intraocular medication has been used which is inadequate for this route. 
Thus, all the surgical team should be aware of this clinical entity, that any substance that is 
introduced into the eye is a possible cause of TASS and the different policies that can be 
incorporated to prevent it. 
9. Overview of Postoperative Endophthalmitis (POE) Prophylaxis 
Postoperative endophthalmitis (POE) is an uncommon but devastating intraocular surgical 
complication (Figure 3). As cataract surgery is by far the most frequently performed 
intraocular operation in the anterior segment, it is also the most frequent cause of POE and 
this has very important clinical, economic and legal consequences (Khan et al., 2005). Of 
note intraocular operations in which large amounts of the vitreous are removed are less 
likely to cause endophthalmitis as vitreous acts as a broth for the microorganisms involved. 
Although it is a rare complication POE is an important public health issue due to the 
progressive aging of the population and the millions of cataract surgery procedures done 
in a year all around the world. It is greatly feared as it can lead to severe and permanent 
visual loss. Over the years the phacoemulsification technique has improved with the use of 
smaller clear corneal incisions, faster surgical times, lens implantation, intraocular 
antibiotics, topical anaesthesia and sutureless wounds but endophthalmitis rates have not 
decreased as much as expected (Melo et al., 2010) (Barry et al., 2006) (Miller et al., 2005). 
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Fig. 3. Postoperative endophthalmitis with severe inflammation. 
POE is an unexpected severe intraocular inflammation which affects both the anterior and 
posterior segments of the eye and is associated with vitreous echoes in both A and B modes 
with ocular ultrasound echography. A differential diagnosis of TASS and retained lens 
material is mandatory to consider. Diagnosis is based on the clinical features but cultures 
from aqueous and vitreous should be done. The most frequent cause is gram positive 
bacteria (Endophthalmitis Vitrectomy Study Group, 1995). Incidence has varied in the past 
decades- in the 1970´s it was 0.32%, in the 1980´s 0.16% and in the 1990´s 0.08%. In the first 
years of the 21st century the incidence increased to 0.26%. Different authors suggest that the 
cause may be non-sutured corneal incisions or postoperative hypotony. Incidence varies 
between series from 0.07% to 0.5% (Díez et al, 2009) (Miller et al., 2005). 
The aims of prophylaxis in cataract surgery are to prevent postoperative endophthalmitis or 
surgical wound infection. Although the need for prophylactic antibiotics in clean surgical 
cases is debated among general surgeons, there is almost uniform agreement among 
ophthalmic surgeons on the need for antibiotic prophylaxis in the clean cataract surgical 
case because of the serious adverse effects associated with endophthalmitis. Some argue that 
antibiotics are not needed for clean surgical cases; however, because of the devastating 
effects of endophthalmitis, antibiotics are almost universally used for elective cataract 
surgery, even in healthy patients. Potential pathogens must be determined as well as local 
resistance patterns. An effective antibiotic must be selected, although no antibiotic is 
effective against all potential pathogens (Liesegang et al., 2001). It is not necessary to cover 
all potential pathogens or to sterilize the operative site, but it is necessary to eliminate most 
bacteria from the site. The least toxic and least expensive antibiotic should be selected; older 
antibiotics are not necessarily obsolete. The antibiotic must be administered at an 
appropriate time and dose. The antibiotic must be in the wound or anterior chamber at the 
time of introduction of organisms if the antibiotic is being used to clear an inoculation of 
introduced organisms. If the objective is to eliminate the bacteria from the surface, then 
topical antibiotics must be given time to work. It is not effective to administer the topical 
antibiotic only at the start of surgery, and it is minimally effective to administer the topical 
antibiotic after the wound is closed. The antibiotic should be administered for the shortest 
time possible and is usually not effective as a prophylactic in the postoperative period.  
It is a general principle in infectious disease to avoid potent antibiotics for prophylaxis, as 
these should be reserved for therapy. If the patient gets a postoperative infection, generally a 
different antibiotic is selected for therapy. There are two approaches to prophylaxis. One is to 
reduce the number of organisms on the surface of the eye by using topically applied antisepsis 
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and/or antibiotics. The other involves diffusion of antibiotics into the ocular tissues during the 
perisurgical period by topical, subconjunctival, systemic, or intracameral route. 
10. Effects on costs and quality of life 
Complications of endophthalmitis affect the patient´s quality of life. These include: loss of 
vision, corneal opacity (21,3%), secondary cataract (40,4%), intraocular pressure increase 
(29,8%), residual vitreous opacity (63.8%), macular epirretinal membrane, retinal 
detachment (6.4%) or even enucleation (Miller et al., 2005). The patient will likely undergo 
intraocular injections, some times vitrectomy, and requires close follow-up. Secondarily, the 
patient may need other operations for the complications mentioned above. All of these 
involve an important decrease in the patient´s quality of life and a significant economic cost. 
11. Risk factors 
11.1 Local risk factors 
Any infectious or even inflammatory local process may be considered as a risk factor for 
POE. Some authors found that chronic use of topical medication, contact lens wear, 
blepharitis, chronic dacriocystitis, and chronic eyelid or conjunctival inflammation were 
associated to higher conjunctival contamination rates and multiresistant bacteria (Miño de 
Kaspar et al., 2003, 2009). Therefore these conditions should be treated prior to elective 
cataract surgery. It is known that external ocular microorganisms are responsible for 
intraocular infection after surgery (Speaker et al., 1991) and presurgical protocols for 
treating bacterial endophthalmitis are not effective to guarantee sterility (Ciulla et al., 2002). 
When preoperative topical drugs for unusual conjunctival bacteria such as coagulase-
negative Staphylocci or Corynebacteria species were used, the organisms grew back 48 
hours after the treatment was interrupted (Fernández Rubio et al., 2004). It was suggested 
that these bacteria had some kind of reservoir from where they colonized the conjunctiva. 
Thus, if more aggressive bacteria remain in the conjunctiva for a long period of time this 
would increase the risk for intraocular contamination after cataract surgery. 
There is a strong association between atopic dermatitis and Staphylococcus (S.) aureus 
conjuntival colonization increasing the risk of intraocular infection due to this organisms 
(Nakata et al., 2000). In patients with chronic blefaritis S. aureus, S. epidermidis, P. acnes 
and corinebacteria were found more frequently (Groden et al., 1991). Gram-positive cocci, S. 
aureus and Streptococcus pneumonaie are associated with acute forms of dacriocystitis 
whilst gram-negative bacteria like Haemophilus influenzae, Pseudomonas species and 
enterobacteria are more frequent in the chronic form (Mills et al., 2007).   
11.2 Senior versus training surgeons 
There is not enough evidence to presume that senior surgeons have lower incidence rates of 
endophthalmitis than residents or fellows (Hollander et al., 2006) (Kamalarajah et al., 2007). 
Training surgeons may have more posterior capsule ruptures whilst senior surgeon may not 
suture as many corneal incisions arising from cataract surgery as the former.  
11.3 Intraocular lens (IOL)  
The role of intraocular lenses in endophthalmitis has not been fully established. Infections 
have been reported with both injectable and non-injectable IOLs. The trend is to use 
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injectable lenses which allow smaller incisions and avoid contact and colonization with 
ocular surface bacteria, thus reducing the risk of an endophthalmitis. There is no difference 
between 1-piece and three-piece IOLs, but there are differences suggesting that silicone IOLs 
are more prone to intraocular infection due to surface factors (ESCRS Endophthalmitis 
Study Group, 2007). The most important factor may be the site of the clear corneal incision, 
in particular, when the incision is temporal (Schauersberger, et al.) (Baillif et al., 2009). 
Cusumano (Cusumano et al., 1994) and Ng (Ng et al., 1996) compared plymethilmethacrylic 
acid (PMMA) and hidrogel IOLs and found statistically significant differences in the 
adhesion of bacteria on the lens surface on non hidrogel lenses. Hidrogel IOLs are foldable, 
highly biocompatible and have a hydrophilic surface leading to a lower risk of 
endophthalmitis. 
IOLs may also have their surface covered in heparine or fluor thus reducing bacteria 
adhesion and therefore inflammation and endophthalimtis (Arciola et al., 1994) (Eloy et al., 
1993). Recently other authors have investigated drug delivery with intraocular lenses 
suggesting that antibiotic-soaked IOLs have potential to become a clinically significant 
technique in the prevention of postoperative endophthalmitis (Shaw et al., 2010).  
11.4 Surgical complications 
Intraoperative complications may increase the risk of POE. Posterior capsule tears with or 
without vitreous loss increases the risk of POE (Driebe et al., 1986) (Menikoff et al., 1991) 
(Kelkar et al., 2008) (Kim et al., 2007). The eye finds it easier to defend against bacteria when 
there is no vitreous in the anterior chamber, in fact, aqueous humour is contaminated in up 
to 20% of all patients at the end of cataract surgery, but only a very low percentage develops 
POE.  
12. Prophylaxis 
12.1 Presurgical prophylaxis 
12.1.1 Topic antibiotics 
Based on heterogeneous evidence, topical antibiotic agents are used worldwide as adjuvant 
of povidone-iodine for postoperative prophylaxis. The goals of prophylactic antibiotics in 
cataract surgery are to reach an optimal concentration in the aqueous humour and cornea 
and to reduce bacterial flora in the lids and conjunctiva sac. To do so, prophylactic treatment 
is started a few days before surgery or the day of surgery or using a combination of these 
strategies.  
Gram-positive species are very common in conjunctival and lid flora. Vasavada et al 
(Vasavada et al., 2008) reported Staphylococcus species as the most prevalent of all being 
cultured in up to 90,4% to 94,4% of asymptomatic people. Of the Staphylococcus species 
isolated, 71% were S. epidermidis. Gram-negative organisms included Pseudomonas 
aeruginosa, Pseudomonas stutzeri, Enterobacter cloacae, Enterobacter hormaechei, Proteus 
vulgari, and Acinetobacter species. The anaerobic cultures mainly consisted of 
Propionibacterium acnes and Peptostreptococcus species. Streptococcus species was present 
in 2% of all specimens.  
The fourth-generation fluoroquinolones moxifloxacin and gatifloxacin achieve high anterior 
chamber concentrations and have a broad bactericidal spectrum. They have similar killing 
rates in vitro studies and appear to be more effective than earlier quinolones (Kowalsky et 
al, 2006). Thus, they are adequate to obtain an effective antibiotic concentration before the 
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anterior chamber is penetrated to allow bacteria inside it. But it should be noted that the 
drug is rapidly washed out once phacoemulsification of the cataract begins.  
12.1.2 Systemic antibiotics 
Prior studies of intravenous antibiotics revealed poor intravitreous penetration. Antibiotics 
that reached significant levels may not reach minimum inhibitory concentration (MIC) for 
many hours. Vancomycin or aminoglycosides failed to reach MIC in phakic human eyes 
with intact vitreous cavities. Some authors consider that fourth generation fluoroquinolones 
should be considered as oral prophylaxis in high-risk patients such as those undergoing 
vitreous loss during cataract surgery, chronic blepharitis, lacrimal drainage obstruction or 
relative inmunocompromise although the authors do not.  
12.2 Surgical prophylaxis in the operating theatre 
12.2.1 Operating room 
POE outbreaks have been reported associated to operating theatre/room air conditioning 
systems, and they are usually caused by Aspergillus rather than bacteria. These outbreaks 
are often related to repairs in the operating theatre. Antiseptic solutions (povidone-iodine, 
clorhexidine), BSS, OVDs, mydriatic and antibiotic drops are also a source of contamination. 
Eye drops can be contaminated with Pseudomonas aeruginosa (Pinna et al., 2009) or 
Fusarium species (Cakir et al., 2009). Where possible, single dose eye drops should be used. 
If not available, a different bottle should be used in every different patient.  
Correct cleaning and sterilization of the instruments is of critical importance and therefore, 
periodic monitoring of protocols and cleaning and sterilization systems are mandatory. The 
authors recommend following the manufacturers’ practice guides focusing on cannulated 
instruments.  
Antisepsia measures of the surgical team are also of chief importance, specially those related 
to hand scrubing. 
12.2.2 Povidone-iodine 
It is know that the most important sources of bacteria responsible for postoperative 
endophthalmitis are those in the conjunctiva and eyelids. One of the measures that have 
proven to be effective in postoperative prophylaxis is to decrease the amount of bacterial 
flora or occasional pathogens. Ciulla et al (Ciulla et al., 2002) describes several prophylactic 
methods concluding that 5% povidone-iodine irrigation before surgery was the most 
strongly recommended prophylactic measure. 
It has proved to be effective against a wide range of bacteria, including methicillin-resistant 
Staphylococcus (MRSA) (Guzel et al., 2009), as well as fungi, protozoa and viruses. It has 
very rapid cytotoxic activity on prokaryotic cells once it reaches the cell wall (Lacey& Catto, 
1993). 
Conjunctival irrigation with 5% povidone-iodine preoperatively is more effective 
eliminating bacteria from the ocular surface than the instillation of 2 drops (Miño de Kaspar 
et al., 2005). Irrigation has a mechanical effect as it washes bacteria away from the surface 
and crypts. A period of time ranging from one to three minutes should be waited for before 
washing povidone-iodine from the ocular surface. The skin of the eye lids and eye lashes 
should be cleaned with 10% povidone-iodine, but note that total sterilization cannot be 
achieved-approximately 20% of the resident flora are resistant to surgical scrubs and 
antiseptics.  
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5% povidone-iodine has been shown to be effective and safe. Its toxicity is limited to 
conjunctival irritation, keratitis and contact dermatitis. The entry of povidone-iodine in the 
anterior chamber should be avoided as it is toxic for the endothelium. Therefore, whenever 
used at the end of the surgery it should only be applied on the surface of the eye once the 
surgeon has made sure the incisions are sealed and the ocular pressure is not low. 
0.5% clorhexidine is safe and effective as an alternative skin disinfectant when the patient is 
allergic to povidone-iodine. It is also safe and effective in diminishing skin colonization with 
Staphylococci in patients before operation. It is not clear though if it is in practice as effective 
as povidone-iodine. 
12.2.3 Draping and topical anaesthesia  
Careful draping of the eyelid margins is of critical importance to reduce the incidence of 
anterior chamber contamination (Masket, 2007). Topical anaesthesia allows the patient to 
blink, which may increase the difficulty to properly retract the eyelids and carefully drape 
the lid margins. Hence, poor draping may be associated with the use of topical anaesthesia. 
There is no clear evidence to suggest topical anaesthesia as a risk factor for postoperative 
endophthalmitis. However, some retrospective studies concluded there was a higher 
incidence of endophthalmitis with topical anaesthesia compared to peribulbar or retrobubar 
anaesthesia (García-Arumi et al., 2007). On the other hand, Greenbaum (Greenbaum, 2007) 
considers the role of more frequent postoperative patching on eyes having retrobulbar 
anaesthesia as the factor which explains the lower incidence of endophthalmitis in these 
patients. 
12.2.4 Corneal incisions 
Two of the most important factors to consider under this topic are postoperative square 
corneal tunnel incisions and ocular hypotony. An entry wound that is distorted during 
surgery is more likely to permit the entrance of fluid from the ocular surface during and 
after the surgery. The width of the incision is also important as it is more dangerous to work 
through a 3.5 mm tunnel than a 2.5 mm tunnel. Another factor is wound localization, where 
temporal localization has been associated with a higher risk of endophthalmitis. 
Furthermore, a low intraocular pressure results in a poor apposition of the edges of the 
wound. The authors routinely hydrate the corneal stroma - this forces the apposition of the 
wound edges. Many critics believe this is a too temporary measure as they believe it lasts for 
1 or 2 hours. Stromal swelling can persist 24 hours or more after the surgery (Fine et al., 
2007). This can be proven with ultrasound.  
Any incision suspected of incompetence should be considered for suturing as it increases 
the risk for potential infection. In the last few years tissue adhesives are gaining popularity. 
There are three possibilities: cyanoacrylate, polymerizing liquid hydrogel and fibrin glue. 
Their role in cataract surgery and in endophthalmitis prophylaxis has not been fully 
established.  
12.2.5 Antibiotics employed in the operating room 
In recent years there has been great controversy on the use of vancomycin as a prophylactic 
agent against endophthalmitis rather than a therapeutic agent. It is a bactericidal antibiotic. 
It is effective against gram-positive pathogens, including methicillin-resistant 
Staphylococcus species and Bacillus cereus. 
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There is fear that its overuse as a prophylactic agent will permit the development of 
multidrug resistant bacteria. To prevent this from occurring, the Centers for Disease Control 
and Prevention (CDC) of the United States, in the year 1995, discouraged the use of 
vancomycin in irrigation solutions or as routine surgical prophylaxis (Centers for Disease 
Control, 1995). Despite these guidelines, many Ophthalmologists continue using it. 
Surgeons who use vancomycin in irrigating solutions justify its use based on the fact that 
there is a potential effect on residual bacteria in the anterior chamber after cataract surgery. 
Ferro, Feys and Mendivil and Mendivil (Ferro et al., 1997) (Feys et al., 1997) (Mendivil A. & 
Mendivil M.P., 2000) failed to demonstrate a bactericidal effect following vancomycin in the 
bottle. In fact, the presence of S. epidermidis was the same in both the prophylaxis and the 
control arms. 
Gordon (Gordon, 2001) believed that vancomycin should not be used as prophylaxis. 
Endophthalmitis has been reported despite its use, it is rapidly washed out from the anterior 
chamber in less than 4 hours and its concentration rapidly falls below MICs of gram-positive 
bacteria. Potentially, bacterial growth could be resumed once the antibiotic is washed-out of 
the anterior chamber. The authors agree with Gordon that there is no scientific evidence to 
use “in the bottle” vancomycin as a routine prophylaxis regimen and therefore do not 
recommend this measure. 
Prophylactic antibiotic bolus injections into anterior chamber were described in the 1970´s. 
In the early 1990´s Gimbel (Gimbel et al., 1994) described a protocol to reduce 
endophthalmitis rates using intracameral vancomycin. After that, Montan (Montan et al., 
2002) chose cefuroxime for endophthalmitis prophylaxis based on the ethiological spectrum 
of their previous endophthalmitis cases. They assumed that gram-negative bacteria would 
account for an insignificant amount of future cases. Thus, this regimen would effectively 
prevent infections due to gram-positive bacteria. They therefore concluded that cefuroxime 
was a valid alternative to vancomycin as a prophylactic agent even though enterococcal 
infections and some gram-negative bacteria were not covered. Vancomycin should be a last-
resort antibiotic agent for treatment and not for prophylaxis, as recommended by the U.S. 
Centers for Disease Control and Prevention, Atlanta, Georgia. (Hospital Infection Control 
Practices Advisory Committee, 1995)  
The European Society of Cataract and Refractive Surgeons (ESCRS) designed a multicentre 
prospective randomized partially masked study to investigate whether the incidence of 
endophthalmitis could be reduced using antibiotics (Barry et al., 2006) (ESCRS 
Endophthalmitis Study Group, 2007). Initially they were to recruit 35.000 patients having 
cataract surgery across several countries in Europe. Treatment effects were so marked that 
16.603 patients were enough to halt the study and reach significant findings. One of the 
most interesting of them was that patients not receiving cefuroxime injection after the 
surgery were 4.92 times more likely to develop endophthtalmitis than patients receiving it. 
Intracameral injection of 1 mg of cefuroxime in 0.1 ml of saline had a statistically significant 
effect in reducing the risk of endophthalmitis after cataract phacoemulsification surgery. 
Previously, a Swedish report had advised of a 5-fold to 6-fold increased risk for 
endopththalmitis in patients not receiving intracameral cefuroxime (Montan et al., 2002). 
Two groups from Spain (Díez et al., 2009) (García-Sáenz et al., 2010) proved cefuroxime to 
be effective and safe in preventing endophthalmitis. Intracamerular cefuroxime proved to be 
more effective than subconjunctival cefuroxime in a paper published in 2008 (Yu-Wai-Man 
et al., 2008). Intracameral cefuroxime has a good safety profile and does not result in 
anterior segment toxicity (Montan et al., 2002) (Díez et al., 2009) (Gupta et al., 2005) (Yoeruek 
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et al., 2008). Once in the anterior chamber, levels of cefuroxime over the MIC are maintained 
approximately 4 hours after the injection. 
Despite the evidence supporting intracameral cephalosporins many surgeons in the United 
States prefer topical fourth-generation fluoroquinolones. They argue that intracameral 
cefuroxime must be prepared in a pharmacy department as it is not commercially available 
thus there is always a certain risk of errors in the dosage, pH, stability or sterility of the 
drug. When prepared in a laminar flux cabin and stored in single patient doses these risks  
can be decreased significantly. Only a relatively small percentage of patients allergic to beta-
lactams are allergic to cephalosporins too. Nevertheless, the authors recommend sending 
them to have allergy tests done before surgery is performed as the benefits of been able to 
use these on patients outweigh many-fold the risk of delaying elective surgery of the eye. 
It has been suggested that moxifloxacin would be preferable to cefuroxime because of its 
broader spectrum of action, better MIC levels and lower bacterial resistance. (O´Brien et al., 
2007) (Scoper, 2008)  (Jensen et al., 2008). Moxifloxacin is available as a self-preserved 
commercial ophthalmic formulation and requires no special preparation for intracameral 
therapy. It has a pH of 6.8 and an osmolality of 290 mOsm/kg (compatible with human 
anterior chamber fluid) (Lane et al., 2008). It is diluted from the commercially available 
drops to a 1 mg/0.1 ml solution as described by Arshinoff (Arshinoff, 2007). Intraocular 
toxicity was shown to be equivalent to standard vancomycin and saline control in a study in 
rabbit eyes by Kowalski (Kowalski et al., 2005). Retinal safety of intravitreal moxifloxacin up 
to 100 µg/ml in mice or 150 µg in rabbits has been shown and caused no electroretinogram 
(ERG) or retinal histologic anormalities. Another study showed the safety of moxifloxacin in 
a concentration of 1 mg/ml and a dose of 100 µg/0.1 ml evaluated by OCT and a 
retrospective review of clinical records (Arbisser, 2008). Lane observed that moxifloxacin in 
an intracameral dose of 250 µg/0.05 ml was as safe as BSS in a 3 month follow up (Lane et 
al., 2008). 
Once injected into the aqueous humour, high initial levels are achieved (710 µg/ml) and 
remained at 6 µg/ml or greater for 4 hours after the injection. This is well above the 
minimum bactericidal concentration against ocular isolates such as Staphylococcus aureus 
(0.13 µg/ml) or Staphylococcus epidermidis (0.25 µg/ml). 
A recent cost-effectiveness analysis published in 2009 revealed that none of the 
fluoroquinolone antibiotics would have theoretical cost-effectiveness ratios superior to 
intracameral cefuroxime. Moreover, to achieve a threshold cost equivalence with 
intracameral cefuroxime, gatifloxacin or moxifloxacin should have an efficacy 9-fold to 30-
fold greater (Sharify et al., 2009). 
Intracameral cefazoline been reported to be used in several papers mainly from Spain. Its 
choice as a prophylactic agent for postoperative endophthalmitis is based on the bacteria 
cultures and antibiograms from their own cases and data published (Garat et al., 2005) 
(Romero et al., 2006). These authors believe that the first-generation cephalosporin 
cefazoline 1 mg in 0.1 ml of saline injected in anterior chamber has a broader spectrum of 
activity against gram-positive bacteria than the second-generation cefuroxime. In fact, both 
cefuroxime and cefazolin have similar physicochemical and pharmacokinetic characteristics. 
Cefazolin is bactericidal against gram-positive cocci, specially Staphylococcus (except for 
methicilin-resistant Staphylococci) and Streptococcus. Garat et al (Garat et al., 2005) use 2.5 
mg/0.1 ml bolus which has proved to be effective reducing endophthalmitis rates from 
0.422% to 0.047% and to be safe. Unfortunately, cefazoline-resistant bacteria such as 
Enterococcus constitute an important gap in the coverage of gram-negative bacteria with 
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this antibiotic. Endophthalmitis due to anaerobic bacteria is not prevented by cefazolin. 
These authors also suggest that cefazolin is easier to obtain and less expensive resulting in a 
very good option for developing countries. Cefazolin is used almost exclusively for surgical 
prophylaxis whereas cefuroxime is used systemically as a therapeutic option potently 
increasing pathogen resistance to the latter. 
12.2.6 Patching 
The use of an eye patch after cataract surgery is part of the postoperative routine in many 
hospitals. So-called “no stitch, no-patch” cataract surgery has become popular in the last few 
years because of modern surgical techniques. There is no clear evidence suggesting an 
influence of patching on the incidence of endophthalmitis. Patients tend to feel safer when 
the operated eye is patched, but it delays the beginning of postoperative antibiotic 
treatment. An alternative procedure may be patching the eye for a few hours and then 
initiating postoperative drop treatment.   
12.3 Postoperative prophylaxis 
12.3.1 Postoperative antibiotics   
Although most ophthalmic surgeons apply an antibiotic ointment or solution at the end of 
the procedure, there is no literature to support the continued use of postoperative 
antibiotics. Several papers have been published on different ophthalmologists´s practices 
worldwide after cataract surgery. Ninety six percent of the ophthalmologists in the United 
States (Masket, 1998) and ninety five percent in Australia (Morlet et al., 1998) answered 
positively when asked if they used postoperative antibiotics to prevent endophthalmitis.   
If antibiotics are prescripted immediately after surgery the authors recommend that their 
use is prolonged until the incisions are sealed and to halt their instillation quickly to 
minimise the risk of development of resistant strains (Guías de Práctica Clínica de la 
Sociedad Española de Retina y Vítreo, 2011) 
13. Conclusions 
As previously discussed, some prophylactic measures have proved to be essential because 
there is scientific evidence to support them whilst others can be incorporated into clinical 
practice although their relevance is yet to be established. 
To summarize, prior to surgery risk factors, especially those which are local, must be 
diagnosed in order to be adequately treated before the patient is booked for surgery. 
Preoperative antibiotics in the absence of risk factors have not been shown to reduce the 
incidence of endophthalmitis. When in the operating theatre proper draping is mandatory 
to ensure lid margin and eye lash isolation from de operating field. Disposable operating 
materials might reduce the risk of contamination and thus may be better than reusable 
material which should be monitored for adequate cleaning and sterilization. 10% povidone-
iodine should be used to clean the skin and 5% should be used in conjunctival fornices for 3 
minutes (grouped evidence rating IIA, clinical recommendation B). In patients who are 
allergic to iodine, clorhexidine is a possible alternative. Care should be taken during corneal 
incision construction. The authors consider that corneal hydration and checking of wounds 
to assess if they are watertight are very useful measures and when there are any doubts 
concerning the wound´s archithecture it should be sutured. There is not enough scientific 
evidence to recommend the use of subconjunctival or “in the bottle” antibiotics for the 
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prophylaxis of endophthalmitis. In a clinical trial promoted by the ESCRS, intracameral 
cefuroxime (1mg in 0.1ml) in the bag and when the anterior chamber was not full, achieved 
a 5-fold decrease in the risk of postoperative endophthamitis (grouped evidence rating IB, 
clinical recommendation A). Its use also has a very good cost-effectiveness ratio. As of the 
present there are no double-masked, randomised clinical trials that recommend 
intracameral moxifloxacin at the end of phacoemulsification for postoperative 
endophthalmitis prophylaxis. Finally, there is no scientific evidence to support antibiotic use 
in the postoperative period to decrease the incidence of POE, but it seems reasonable to use 
them until the incisions are sealed- this normally means a week of topical antibiotics. Sharp 
suspension of the treatment and not tapering of these drops is recommended.  
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